JM

Jean Marc Francis Gendre

Active Director Director DIN 09576466
DIN 09576466 First appointment Apr 2022 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2022
Shareholding value •••• Premium profile

About Jean Marc Francis Gendre

Data last updated:

Jean Marc Francis Gendre is a Director at Lumibird Medical India Private Limited (since 2022). The company operates in Trading. Lumibird Medical India Private Limited reported revenue of ₹12.3 Lakh (FY 2024).

DIN 09576466
Primary Designation Director
Industry Trading
First Appointment 19 Apr 2022
Oldest Company Age 4 yrs
Largest company Lumibird Medical India Private Limited · ₹12.3 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director19 Apr 20222022₹12.3 Lakh (FY 2024)Active

Board colleagues of Jean Marc Francis Gendre

Directorship timeline

Open interactive timeline →
Lumibird Medical India Private Limited
Premium access

Shareholding and investment profile for Jean Marc Francis Gendre

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jean Marc Francis Gendre

Jean Marc Francis Gendre currently holds 1 directorship: Lumibird Medical India Private Limited (Director, since 19 Apr 2022, revenue ₹12.3 Lakh (FY 2024)).

Jean Marc Francis Gendre was first appointed on 19 Apr 2022 as Director at Lumibird Medical India Private Limited.

The current boards of Jean Marc Francis Gendre's companies include Jatin Rameshchandra Desai (Lumibird Medical India Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available